Laurel Wealth Advisors (North Carolina)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.9M | Sell |
14,057
-147
| -1% | -$150K | 1.63% | 14 |
|
|
2026
Q1 | $13.5M | Sell |
14,204
-157
| -1% | -$159K | 1.33% | 15 |
|
|
2025
Q4 | $15.4M | Sell |
14,361
-652
| -4% | -$623K | 2.04% | 11 |
|
|
2025
Q3 | $11.5M | Buy |
15,013
+193
| +1% | +$144K | 1.6% | 16 |
|
|
2025
Q2 | $11.6M | Buy |
14,820
+145
| +1% | +$113K | 1.73% | 15 |
|
|
2025
Q1 | $12.1M | Sell |
14,675
-731
| -5% | -$608K | 1.9% | 14 |
|
|
2024
Q4 | $11.9M | Sell |
15,406
-429
| -3% | -$355K | 1.86% | 14 |
|
|
2024
Q3 | $14M | Sell |
15,835
-857
| -5% | -$770K | 2.24% | 10 |
|
|
2024
Q2 | $15.1M | Sell |
16,692
-652
| -4% | -$522K | 2.62% | 8 |
|
|
2024
Q1 | $13.5M | Sell |
17,344
-334
| -2% | -$238K | 2.3% | 9 |
|
|
2023
Q4 | $10.3M | Sell |
17,678
-478
| -3% | -$279K | 1.95% | 12 |
|
|
2023
Q3 | $9.75M | Sell |
18,156
-1,684
| -8% | -$868K | 2.06% | 9 |
|
|
2023
Q2 | $9.3M | Sell |
19,840
-1,096
| -5% | -$460K | 1.86% | 13 |
|
|
2023
Q1 | $7.19M | Buy |
20,936
+430
| +2% | +$145K | 1.52% | 15 |
|
|
2022
Q4 | $7.5M | Sell |
20,506
-395
| -2% | -$140K | 1.7% | 16 |
|
|
2022
Q3 | $6.76M | Sell |
20,901
-150
| -0.7% | -$47.5K | 1.68% | 15 |
|
|
2022
Q2 | $6.83M | Sell |
21,051
-125
| -0.6% | -$37.5K | 1.65% | 16 |
|
|
2022
Q1 | $6.06M | Sell |
21,176
-387
| -2% | -$99.6K | 1.27% | 23 |
|
|
2021
Q4 | $5.96M | Sell |
21,563
-210
| -1% | -$53.2K | 1.22% | 23 |
|
|
2021
Q3 | $5.03M | Sell |
21,773
-399
| -2% | -$98.5K | 1.11% | 26 |
|
|
2021
Q2 | $5.09M | Sell |
22,172
-355
| -2% | -$71.3K | 1.1% | 26 |
|
|
2021
Q1 | $4.21M | Sell |
22,527
-517
| -2% | -$101K | 1.02% | 28 |
|
|
2020
Q4 | $3.89M | Buy |
23,044
+180
| +0.8% | +$26.9K | 1.01% | 28 |
|
|
2020
Q3 | $3.38M | Buy |
22,864
+495
| +2% | +$76.6K | 1.01% | 30 |
|
|
2020
Q2 | $3.67M | Sell |
22,369
-231
| -1% | -$35.5K | 1.21% | 24 |
|
|
2020
Q1 | $3.13M | Sell |
22,600
-180
| -0.8% | -$24.7K | 1.18% | 26 |
|
|
2019
Q4 | $2.99M | Buy |
22,780
+56
| +0.2% | +$6.49K | 0.94% | 34 |
|
|
2019
Q3 | $2.54M | Buy |
22,724
+71
| +0.3% | +$7.91K | 0.87% | 36 |
|
|
2019
Q2 | $2.51M | Buy |
22,653
+176
| +0.8% | +$20.7K | 0.88% | 36 |
|
|
2019
Q1 | $2.92M | Sell |
22,477
-374
| -2% | -$45.5K | 1.07% | 29 |
|
|
2018
Q4 | $2.64M | Buy |
+22,851
| New | +$2.55M | 1.06% | 30 |
|
Other funds holding LLY
Laurel Wealth Advisors (North Carolina)'s LLY Position: Q2 2026 in Review
Laurel Wealth Advisors (North Carolina) reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $150K and leaving 14,057 shares worth $16.9M. The position accounts for 1.63% of the portfolio, ranked #14.
Laurel Wealth Advisors (North Carolina) first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Laurel Wealth Advisors (North Carolina) held 14,057 shares of Eli Lilly worth $16.9M as of Q2 2026.
- Laurel Wealth Advisors (North Carolina) sold 147 Eli Lilly shares in Q2 2026, an estimated $150K.
- Eli Lilly made up 1.63% of Laurel Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #14 holding.
- Laurel Wealth Advisors (North Carolina) first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 17 Jul 2026.